Get the Stockscreener App
13.52
6.11%
-0.88
Exozymes Inc stock is traded at $13.52, with a volume of 1,678.
It is down -6.11% in the last 24 hours and up +1.65% over the past month.
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
See More
Previous Close:
$14.40
Open:
$13.98
24h Volume:
1,678
Relative Volume:
0.49
Market Cap:
$113.40M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+9.34%
1M Performance:
+1.65%
6M Performance:
+24.15%
1Y Performance:
+0.00%
1-Day Range:
$13.52
$13.98
1-Week Range:
$12.36
$14.89
52-Week Range:
$8.86
$22.63
Exozymes Inc Stock (EXOZ) Company Profile
Name
Exozymes Inc
Sector
Industry
Phone
(626) - 415 - 1488
Address
750 ROYAL OAKS DR, MONROVIA
Compare EXOZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EXOZ
Exozymes Inc
|
13.52 | 120.78M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Exozymes Inc Stock (EXOZ) Latest News
Can a trend reversal in eXoZymes Inc. lead to recoveryPortfolio Growth Summary & Community Verified Trade Alerts - newser.com
Can technical indicators confirm eXoZymes Inc.’s reversalPortfolio Value Summary & AI Enhanced Market Trend Forecasts - newser.com
Evaluating eXoZymes Inc. with trendline analysisIPO Watch & Consistent Growth Stock Picks - newser.com
Order flow analysis tools used on eXoZymes Inc.July 2025 Fed Impact & Stock Portfolio Risk Management - newser.com
What recovery options are there for eXoZymes Inc.July 2025 Selloffs & Accurate Technical Buy Alerts - newser.com
eXoZymes Inc.’s volatility index tracking explained2025 Volatility Report & Real-Time Market Trend Scan - newser.com
Why eXoZymes Inc. stock is a must watch in 2025Quarterly Portfolio Report & High Accuracy Trade Signal Alerts - newser.com
How eXoZymes Inc. stock performs in weak economyJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - newser.com
Will eXoZymes Inc. stock deliver strong dividend growthMarket Risk Analysis & Short-Term High Return Ideas - newser.com
What data driven models say about eXoZymes Inc.’s futureJuly 2025 Big Picture & Low Drawdown Investment Ideas - newser.com
Heatmap analysis for eXoZymes Inc. and competitors2025 Trading Volume Trends & High Accuracy Swing Trade Signals - newser.com
How to use Fibonacci retracement on eXoZymes Inc.Earnings Summary Report & Community Driven Trade Alerts - newser.com
CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference - ACCESS Newswire
Will eXoZymes Inc. stock maintain dividend yield2025 Major Catalysts & Real-Time Price Movement Reports - newser.com
CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference - Lelezard
eXoZymes (NASDAQ: EXOZ) CEO to present 11:20 AM Nov 3 at Spartan Capital conference - Stock Titan
Published on: 2025-10-29 04:08:52 - newser.com
How to manage a losing position in eXoZymes Inc.July 2025 Opening Moves & Fast Gaining Stock Reports - newser.com
How supply chain issues affect eXoZymes Inc. stockWeekly Volume Report & Consistent Growth Stock Picks - fcp.pa.gov.br
How eXoZymes Inc. stock benefits from tech adoption2025 Year in Review & Fast Gaining Stock Reports - fcp.pa.gov.br
Exozymes Inc Stock (EXOZ) Financials Data
There is no financial data for Exozymes Inc (EXOZ). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):